CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. lifted its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 56,033 shares of the company’s stock after purchasing an additional 1,256 shares during the period. Envestnet Asset Management Inc.’s holdings in CRISPR Therapeutics were worth $2,205,000 at […]
